A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects
Status:
Terminated
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, cross-over, vehicle-controlled study to determine whether
GS-5737 in 2.8% saline accelerates mucociliary clearance (MCC) in healthy subjects, compared
to vehicle of 2.8% saline alone.